Abstract
The introduction of opioids in the clinical practice of anesthesia was a revolution. By blocking the sympathetic response to surgical stimuli and obtaining a reduced requirement of hypnotic agents, a safer and a more stable hemodynamically perioperative period was made possible. However, administration of opioids can be associated with several side effects that can be responsible for delayed patient recovery and hospital discharge, as well as leading to increased health service costs. Furthermore, opioid use is related to a wide range of side effects including gastrointestinal (nausea, vomiting, ileus), respiratory (decreased central respiratory drive impacting respiratory rate, and tidal volume), central nervous system effects (sedation, delirium, dysphoria, catalepsy, hallucinations) effects, as well as urinary retention, pruritus, bradycardia, and dizziness. Another undesired effect of opioids as primary pain therapy in the perioperative period, is the development of “acute tolerance” to the analgesic effect of these drugs. This diminished analgesic effect may also be the result of the “opioid-induced hyperalgesia” (OIH) phenomenon. Again, some evidence has suggested that opioids may interfere with the immune system. Numerous studies have shown that opioids can influence the progression of cancer, metastasis, and cancer recurrence. In the 1990s, in the light of experience and studies conducted on opioids and their effects within the broader context of multimodal analgesia, their use came into question. New anesthesia techniques started to be developed that aimed to achieve the sparing use of opioids. These approaches culminated, in the 2000s, with the development of opioid-free anesthesia (OFA) pathways. The strategy of OFA is a realistic alternative that can lead to enhanced recovery and increased patient satisfaction by reducing important opioid related side effects; it can also facilitate the use of lower doses of opioids postoperatively in order to achieve a pain-free recovery and reduce pain scores while providing faster and safer mobilization and rehabilitation. The drugs used are hypnotics, N-methyl-d-aspartate (NMDA) antagonists (ketamine, magnesium sulfate), sodium channel blockers (local anesthetics), anti-inflammatory drugs [nonsteroidal anti-inflammatory drugs (NSAIDs), dexamethasone, local anesthetic], and alpha-2 agonists (dexmedetomidine, clonidine). The association of OFA and locoregional anesthetic techniques is very common. Several types of patients can benefit from this technique including narcotic history patients, obese patients with obstructive sleep apnea, patients with hyperalgesia and history of chronic pain, immune deficiency individuals, patients undergoing oncologic surgery as well as those affected by inflammatory conditions, chronic obstructive pulmonary disease, and asthma. While different OFA protocols have been reported in the literature, the publications rely mostly on case reports and small size investigations. More studies are necessary to assess what the interactions between these drugs are. Clinical researchers must design studies with rigorous methodology in order to correctly assess the risks and benefits of OFA for patients in different surgical settings.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cohen MM (1969) The history of opium and opiates. Tex Med 65:76–85
Yim M, Parsa FD (2018) From the origins of the opioid use (and misuse) to the challenge of opioid-free pain management in surgery. Pain Treat. https://doi.org/10.5772/intechopen.82675
Janssen PA (1982) Potent new analgesics tailor-made for different purposes. Acta Anaesthesiol Scand 26:262–268
Duarte DF (2005) Opium and opioids: a brief history. Rev Bras Anestesiol 55(1):135–146
Chia YY et al (1999) Intraoperative high dose fentanyl induces postoperative fentanyl tolerance. Can J Anaesth 46:872–877
Guignard B et al (2000) Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine requirement. Anesthesiology 93:409–417
Cuomo A, Bimonte S, Forte CA et al (2019) Multimodal approaches and tailored therapies for pain management: the trolley analgesic model. J Pain Res 12:711–714. https://doi.org/10.2147/JPR.S178910
Elkassabany NM, Mariano ER (2019) Opioid-free anaesthesia – what would Inigo Montoya say? Anesth Edit 74(5):560–563. https://doi.org/10.1111/anae.14611
Kehlet H, Dahl JB (1993) The value of “multimodal” or “balanced analgesia” in postoperative pain treatment. Anesth Analg 77(5):1048–1056
Mulier J (2017) Opioid free general anesthesia: a paradigm shift? Rev Españ Anestesiol Reanim 64(8):427–430
Weinbroum A (2015) Role of anaesthetics and opioids in perioperative hyperalgesia. Eur J Anaesthesiol 32:230–231
Van Zee A (2009) The promotion and marketing of oxycontin: commercial triumph, public health tragedy. Am J Public Health 99(2):221–227
Joly V, Richebe P, Guignard B et al (2005) Remifentanil-induced postoperative hyperalgesia and its prevention with small-dose ketamine. Anesthesiology 103(1):147–155
Brummett CM, Waljee JF, Goesling J et al (2017) New persistent opioid use after minor and major surgical procedures in US adults. JAMA Surg 152(6):e170504. https://doi.org/10.1001/jamasurg.2017.0504
Shah A, Hayes CJ, Martin BC (2017) Factors influencing long-term opioid use among opioid naive patients: an examination of initial prescription characteristics and pain etiologies. J Pain 18(11):1374–1383. https://doi.org/10.1016/j.jpain.2017.06.010
Levy N, Mills P (2018) Controlled-release opioids cause harm and should be avoided in management of postoperative pain in opioid naı¨ve patients. Br J Anaesth 122(6):e86–e90. https://doi.org/10.1016/j.bja.2018.09.005
Dumas EO (2018) Opioid tolerance development: a pharmacokinetic/pharmacodynamic perspective. AAPS J 4:537
Allouche S, Noble F, Marie N (2014) Opioid receptor desensitization: mechanisms and its link to tolerance. Front Pharmacol 5:280
Hayhurst CJ, Durieux ME (2016) Differential opioid tolerance and opioid-induced hyperalgesia: a clinical reality. Anesthesiology 2(124):483–488
Fletcher D, Martinez V (2014) Opioid-induced hyperalgesia in patient after surgery: a systematic review and a meta-analysis. Br J Anesth 112(6):991–1004
Afsharimani B, Baran J, Watanabe S (2014) Morphine and tumor growth and metastasis. Clin Exp Metastasis 31(2):149–158. https://doi.org/10.1007/s10585-013-9616-3
Gach K, Wyrębska A, Fichna J et al (2011) The role of morphine in regulation of cancer cell growth. Naunyn Schmiedeberg’s Arch Pharmacol 384(3):221–230. https://doi.org/10.1007/s00210-011-0672-4
Gupta K, Kshirsagar S, Chang L (2002) Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Res 62(3):4491–4498
Lennon FE, Mirzapoiazova T, Mambetsariev B (2012) Overexpression of the mu-opioid receptor in human non-small cell lung cancer promotes Akt and mTor activation, tumor growth, and metastasis. Anesthesiology 116(4):857–867
Mathew B, Lennon FE, Siegler J (2011) The novel role of the mu-opioid receptor in lung cancer progression: a laboratory investigation. Anesth Analg 112(3):558–567
Singleton PA, Mirzapoiazova T, Hasina R (2014) Increased mu-opioid receptor expression in metastatic lung cancer. Br J Anaesth 113(Suppl 1):i103–i108
Bimonte S, Barbieri A, Cascella M et al (2019) Naloxone counteracts the promoting tumor growth effects induced by morphine in an animal model of triple-negative breast cancer. In Vivo 33(3):821–825
Frauenknecht J, Kirkham KR, Jacot-Guillarmod A (2019) Analgesic impact of intra-operative opioid vs. opioid-free anaesthesia: a systematic review and meta-analysis. Anesthesia 74(5):651–662. https://doi.org/10.1111/anae.14582
Kawasaki Y, Kohno T, Zhuang ZY et al (2004) Ionotropic and metabotropic receptors, protein kinase A, protein kinase C, and Src contribute to C-fiber-induced ERK activation and cAMP response element-binding protein phosphorylation in dorsal horn neurons, leading to central sensitization. J Neurosci 24(38):8310–8321
Thompson T, Whiter F, Gallop K et al (2019) NMDA receptor antagonists and pain relief A meta-analysis of experimental trials. Neurology 92(14):e1652–e1662. https://doi.org/10.1212/WNL.0000000000007238
Guillou N, Tanguy M, Seguin P et al (2003) The effects of small-dose ketamine on morphine consumption in surgical intensive care unit patients after major abdominal surgery. Anesth Analg 97(3):843–847
Yang Y, Cui Y, Sang K et al (2018) Ketamine blocks bursting in the lateral habenula to rapidly relieve depression. Nature 554(7692):317–322
Kirby T (2015) Ketamine for depression: the highs and lows. Lancet Psychiatry 9:783–784. https://doi.org/10.1016/S2215-0366(15)00392-2
Gorlin AW, Rosenfeld DM, Ramakrishna H (2016) Intravenous sub-anesthetic ketamine for perioperative analgesia. J Anaesthesiol Clin Pharmacol 2:160–167. https://doi.org/10.4103/0970-9185.182085
Feria M, Abad F, Sanchez A et al (1993) Magnesium sulphate injected subcutaneously suppresses autotomy in peripherally deafferented rats. Pain 53:287–293
McCarthy RJ, Kroin JS, Tuman KJ et al (1998) Antinociceptive potentiation and attenuation of tolerance by intrathecal co-infusion of magnesium sulfate and morphine in rats. Anesth Analg 86:830–836
Albrecht E, Kirkham KR, Liu SS (2013) Peri-operative intravenous administration of magnesium sulphate and postoperative pain: a meta-analysis. Anaesthesia 68(1):79–90. https://doi.org/10.1111/j.1365-2044.2012.07335.x
Kawamata M, Sugino S, Narimatsu E et al (2006) Effects of systemic administration of lidocaine and QX-314 on hyperexcitability of spinal dorsal horn neurons after incision in the rat. Pain 122:68–80
Abelson KS, Hoglund AU (2002) Intravenously administered lidocaine in therapeutic doses increases the intraspinal release of acetylcholine in rats. Neurosci Lett 317:93–96
Wright J, Durieux M, Groves D (2008) A brief review of innovative uses for local anesthetics. Curr Opin Anaesthesiol 21(5):651–656
Dunn LK, Durieux ME (2017) Perioperative use of intravenous lidocaine. Anesthesiology 126(4):729–737. https://doi.org/10.1097/ALN.0000000000001527
Koppert W, Weigand M, Neumann F et al (2004) Perioperative intravenous lidocaine has preventive effects on postoperative pain and morphine consumption after major abdominal surgery. Anesth Analg 98:1050–1055
Herroeder S, Pecher S, Schönherr ME et al (2007) Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, saline-controlled trial. Ann Surg 246:192–200
Tikuišis R, Miliauskas P, Samalavičius NE et al (2014) Intravenous lidocaine for post-operative pain relief after hand-assisted laparoscopic colon surgery: a randomized, saline-controlled clinical trial. Tech Coloproctol 18(4):373–380. https://doi.org/10.1007/s10151-013-1065-0
Weibel S, Jelting Y, Pace NL et al (2018) Intravenous infusion of lidocaine starting at the time of surgery for reduction of pain and improvement of recovery after surgery. Cochrane Database Syst Rev 6:Art. No.:CD009642
Eipe N, Gupta S, Penning J (2016) Intravenous lidocaine for acute pain: an evidence-based clinical update. BJA Education 16(9):292–298
Dexamethasone (DB01234) – dexamethasone- DrugBank. https://www.drugbank.ca/drugs/DB01234. Accessed 27 May 2019
De Oliveira GS Jr, Castro-Alves LJ, Ahmad S et al (2013) Dexamethasone to prevent postoperative nausea and vomiting: an updated meta-analysis of randomized controlled trials. Anesth Analg 116:58–74
Pehora C, Pearson AM, Kaushal A et al (2017) Dexamethasone as an adjuvant to peripheral nerve block. Cochrane Database Syst Rev 11:CD011770
De Oliveira GS Jr, Almeida MD, Benzon HT et al (2012) Perioperative single dose systemic dexamethasone for postoperative pain: a meta-analysis of randomized controlled trials. Anesthesiology 115:575–588. https://doi.org/10.1097/ALN.0b013e31822a24c2
Fauci AS, Dale DC, Balow JE (1976) Glucocorticosteroid therapy: mechanisms of action and clinical considerations. Ann Intern Med 84:304–315
Polderman JAW, Farhang-Razi V, van Dieren S et al (2019) Adverse side-effects of dexamethasone in surgical patients – an abridged. Cochrane systematic review. Anaesthesia. https://doi.org/10.1111/anae.14610
Davies DS, Wing LHM, Reid JL et al (1997) Pharmacokinetics and concentration-effect relationships of intravenous and oral clonidine. Clin Pharmacol Ther 21:593–601
Lowenthal DT, Matzek KM, MacGregor TR (1988) Clinical pharmacokinetics of clonidine. Clin Pharmacokinet 14:287–310
Sanchez Munoz MC, De Kock M, Forget P (2017) What is the place of clonidine in anesthesia? Systematic review and meta-analyses of randomized controlled trials. J Clin Anesth 38:140–153. https://doi.org/10.1016/j.jclinane.2017.02.003
Carabine UA, Wright PM, Moore J (1991) Preanaesthetic medication with clonidine: a dose-response study. Br J Anaesth 67(1):79–83
Wagner DS, Brummett CM (2006) Dexmedetomidine: as safe as safe can be. Semin Anesth Perioper Med Pain 25:77–83
Fairbanks CA, Stone LS, Wilcox GL (2009) Pharmacological profiles of alpha 2 adrenergic receptor agonists identified using genetically altered mice and isobolographic analysis. Pharmacol Ther 123(2):224–238
Afsani N (2010) Clinical application of dexmedetomidine. S Afr J Anaesthesiol Analg 16:50–56
Scheinin B, Lindgren L, Randell T et al (1992) Dexmedetomidine attenuates sympathoadrenal responses to tracheal intubation and reduces the need for thiopentone and peroperative fentanyl. Br J Anaesth 68(2):126–131
Guler G, Akin A, Tosun Z et al (2005) Single-dose dexmedetomidine attenuates airway and circulatory reflexes during extubation. Acta Anaesthesiol Scand 49(8):1088–1091
Bekker A, Sturaitis MK (2005) Dexmedetomidine for neurological surgery. Neurosurgery 57(1 Suppl):1–10. discussion 1–10
Scott-Warren VL, Sebastian J (2016) Dexmedetomidine: its use in intensive care medicine and anaesthesia. BJA Edu 16(7):242–246
Sultana A, Torres D, Schumann R (2017) Special indications for opioid free anaesthesia and analgesia, patient and procedure related: including obesity, sleep apnoea, chronic obstructive pulmonary disease, complex regional pain syndromes, opioid addiction and cancer surgery. Best Pract Res Clin Anaesthesiol 31(4):547–560. https://doi.org/10.1016/j.bpa.2017.11.002
Bakan M, Umutoglu T, Topuz U et al (2015) Opioid-free total intravenous anesthesia with propofol, dexmedetomidine and lidocaine infusions for laparoscopic cholecystectomy: a prospective, randomized, double-blinded study. Braz J Anesthesiol 65(3):191–199. https://doi.org/10.1016/j.bjane.2014.05.001
Aronsohn J, Orner G, Palleschi G et al (2019) Opioid-free total intravenous anesthesia with ketamine as part of an enhanced recovery protocol for bariatric surgery patients with sleep disordered breathing. J Clin Anesth 52:65–66
Landry E, Burns S, Pelletier MP et al (2018) A successful opioid- free anesthetic in a patient undergoing cardiac surgery. J Cardiothorac Vasc Anesth pii:S1053-0770(18)31092-9. https://doi.org/10.1053/j.jvca.2018.11.040
Hontoir S, Saxena S, Gatto P et al (2016) Opioid-free anesthesia: what about patient comfort? A prospective, randomized, controlled trial. Acta Anaesthesiol Belg 67(4):183–190
Bello M, Oger S, Bedon-Carte S (2019) Effect of opioid-free anaesthesia on postoperative epidural ropivacaine requirement after thoracic surgery: a retrospective unmatched case-control study. Anaesth Crit Care Pain Med pii:S2352-5568(18)30281-9. https://doi.org/10.1016/j.accpm.2019.01.013
Boloeil H, Lavoille B, Menard C et al (2018) POFA trial study protocol: a multicentre, double-bind,randomized, controlled clinical trial comparing opioid-free versus opioid anaesthesia on postoperative opioid-related adverse events after major or intermediate non-cardiac surgery. BMJ Open 8(6):e020873. https://doi.org/10.1136/bmjopen-2017-020873
Cascella M, Muzio MR, Bimonte S, Cuomo A, Jakobsson JG (2018) Postoperative delirium and postoperative cognitive dysfunction: updates in pathophysiology, potential translational approaches to clinical practice and further research perspectives. Minerva Anestesiol 84(2):246–260
Kim N, Matzon JL, Abboudi J et al (2016) A prospective evaluation of opioid utilization after upper-extremity surgical procedures. J Bone Joint Surg Am 98(20):e89
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Khalife, M., Biter, G., Cascella, M., Napoli, R.D. (2020). The Challenge of Opioid-Free Anesthesia. In: Cascella, M. (eds) General Anesthesia Research. Neuromethods, vol 150. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9891-3_11
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9891-3_11
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9890-6
Online ISBN: 978-1-4939-9891-3
eBook Packages: Springer Protocols